journal article·2023-12-13Open access

Intra-articular Histone Deacetylase Inhibitor Microcarrier Delivery to Reduce Osteoarthritis

Jing Ye, Ronghui Deng, Xinjie Wang, Shitang Song, Xiong Xu, Ji-Ying Zhang, Bing-bing Xu, Xing Wang, Jia-Kuo Yu

Nano Letters· Volume 23· Issue 23

Abstract

High Resolution Image Download MS PowerPoint Slide The histone deacetylase inhibitor (HDACi) was a milestone in the treatment of refractory T-cell lymphoma. However, the beneficial effects of HDACi have not been appreciated in osteoarthritis (OA). Herein, we implemented a microcarrier system because of the outstanding advantages of controlled and sustained release, biodegradability, and biocompatibility. The poly( d,l -lactide- co -glycolide) (PLGA) microcapsules have a regulated and sustained release profile with a reduced initial burst release, which can improve the encapsulation efficiency of the Chidamide. The emulsion solvent evaporation strategy was used to encapsulate Chidamide in PLGA microcapsules. The encapsulation of Chidamide was established by UV–vis spectra and scanning electron microscopy. Additionally, the inhibition of Tnnt3 and immune stimulation by Chidamide helped to inhibit cartilage destruction and prevent articular cartilage degeneration. Based on the results, the Chidamide in PLGA microcapsules provides a transformative therapeutic strategy for the treatment of osteoarthritis patients to relieve symptoms and protect against cartilage degeneration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Histone Deacetylase Inhibitors Research · Knee injuries and reconstruction techniques · Osteoarthritis Treatment and Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China

Institute of Sports Medicine, Peking University, No. 49 North Garden Road, Haidian District, Beijing 100191, China

Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China

University of Chinese Academy of Sciences, Beijing 100049, China

Funding

National Natural Science Foundation of China

References (27)

Show source-provided references
1. 10.1136/annrheumdis-2013-20335510.1136/annrheumdis-2013-203355 ↗
2. 10.1038/nrrheum.2014.4410.1038/nrrheum.2014.44 ↗
3. 10.1007/978-981-13-3681-2_610.1007/978-981-13-3681-2_6 ↗
4. 10.1016/S0140-6736(19)30417-910.1016/S0140-6736(19)30417-9 ↗
5. 10.1016/j.mcna.2019.10.00710.1016/j.mcna.2019.10.007 ↗
6. 10.5694/mja12.1114910.5694/mja12.11149 ↗
7. 10.5694/mja12.1121010.5694/mja12.11210 ↗
8. 10.1016/j.cger.2021.11.01310.1016/j.cger.2021.11.013 ↗
9. 10.1038/nrrheum.2017.16010.1038/nrrheum.2017.160 ↗
10. 10.1016/j.pharmthera.2019.10743710.1016/j.pharmthera.2019.107437 ↗
11. 10.1080/2162402X.2021.193566810.1080/2162402X.2021.1935668 ↗
12. 10.1158/1078-0432.CCR-15-258410.1158/1078-0432.CCR-15-2584 ↗
13. 10.1158/1078-0432.CCR-17-046610.1158/1078-0432.CCR-17-0466 ↗
14. 10.3390/cells1001001210.3390/cells10010012 ↗
15. 10.1186/s12967-020-02318-810.1186/s12967-020-02318-8 ↗
16. 10.7150/ijbs.6233910.7150/ijbs.62339 ↗
17. 10.3390/cancers1111179410.3390/cancers11111794 ↗
18. 10.3389/fcell.2020.56011710.3389/fcell.2020.560117 ↗
19. 10.1136/ard-2021-22126910.1136/ard-2021-221269 ↗
20. 10.1186/s13075-015-0774-310.1186/s13075-015-0774-3 ↗
21. 10.1186/s13287-020-01885-310.1186/s13287-020-01885-3 ↗
22. 10.1007/s40520-019-01191-w10.1007/s40520-019-01191-w ↗
23. 10.1007/s10067-018-4263-310.1007/s10067-018-4263-3 ↗
24. 10.1016/j.joca.2019.06.01110.1016/j.joca.2019.06.011 ↗
25. 10.1001/jama.2020.839510.1001/jama.2020.8395 ↗
26. 10.1038/s41598-022-10518-z10.1038/s41598-022-10518-z ↗
27. 10.2119/molmed.2011.0005810.2119/molmed.2011.00058 ↗